Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
9,773,518
-
Share change
-
-940,099
-
Total reported value
-
$8,012,264
-
Price per share
-
$0.82
-
Number of holders
-
31
-
Value change
-
-$844,234
-
Number of buys
-
10
-
Number of sells
-
22
Institutional Holders of EDGE THERAPEUTICS INC - COM (EDGE) as of Q3 2018
As of 30 Sep 2018,
EDGE THERAPEUTICS INC - COM (EDGE) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,773,518 shares.
The largest 10 holders included
Sofinnova Ventures Inc, New Leaf Venture Partners, L.L.C., Ghost Tree Capital, LLC, Vanguard Group Inc, D. E. Shaw & Co., Inc., BlackRock Inc., TWO SIGMA INVESTMENTS, LP, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, and Raymond James Financial Services Advisors, Inc..
This page lists
31
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.